Prolactin effect on blood glucose and insülin in breastfeeding women.


Journal

Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250

Informations de publication

Date de publication:
Historique:
received: 10 03 2019
accepted: 29 03 2019
entrez: 26 6 2019
pubmed: 27 6 2019
medline: 19 12 2019
Statut: ppublish

Résumé

Prolactin plays a significant role in lactation and prolactin levels are increasing physiologically in pregnancy and breastfeeding period. There might be different mechanisms during breastfeeding between prolactin and insülin levels. In order to highlighten this mechanisms we compared the plasma levels of glucose, insülin, prolactin, C-peptid in basal situations and after taking 75 gr carbonhydrate, 20 gr protein, 23 gr fat in breastfeeding and in non lactating women. Participiants and measurements: The study population included 12 breastfeeding women and 11 healthy non lactating women as a control group. We collected information on age, history of gestational diabetes mellitus, family history of diabetes mellitus, natality, the symptoms of hypoglycemia. Weight, height and waist circumference were measured and body mass index (BMI) was calculated as weight (kg)/height (m Prolactin was inversely correlated with HbA1c and 2. hour C peptide (p=0.005, r=-0.564; p=0.008, r=-0.539). Prolactin was not significantly correlated with HOMA-IR, HOMA-IS, AUC-I or AUC-G. Prolactin levels were higher in breastfeeding women (median:34.98 μg/L) than in non lactating women (median:12.21 μg/L, p<0.001). There was a significant association between age and fasting glucose (p=0.018, r=-0.665), 2. hour glucose (p=0.049, r=0.578) in breastfeeding women. In our study, we displayed prolactin was inversely correlated with HbA1c and 2. hour C peptide. Some studies in the past demonstrated that higher prolactin levels had importantly lower prevelance of type 2 diabetes. Our findings supported this situation.

Identifiants

pubmed: 31235091
pii: S1871-4021(19)30173-0
doi: 10.1016/j.dsx.2019.03.045
pii:
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
C-Peptide 0
Glycated Hemoglobin A 0
Insulin 0
hemoglobin A1c protein, human 0
Prolactin 9002-62-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1765-1767

Informations de copyright

Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Auteurs

Hatice Ozisik (H)

Ege University, Faculty of Medicine, Department of Endocrinology, İzmir, Turkey. Electronic address: yasdikhatice@yahoo.com.

Aslı Suner (A)

Ege University, Faculty of Medicine, Department of Biostatistics, İzmir, Turkey.

Sevki Cetinkalp (S)

Ege University, Faculty of Medicine, Department of Endocrinology, İzmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH